A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)M.B. Long, James D. Chalmers, Adam T. Hill et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 8
Sputum proteomics uncovers the heterogeneity of Pseudomonas aeruginosa infections in bronchiectasisRebecca C Hull, James D. Chalmers, Hollian Richardson et al.|Unknown|2024Cited by 1
Evaluation of rapid multiplex PCR for investigation of lung microbiology in bronchiectasis – preliminary data from the BRILLIANT studyLucy Bidgood, James D. Chalmers, Maria G. Belvisi et al.|Unknown|2024Cited by 0
Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE studyHannah Dickson, James D. Chalmers, Robert Lord et al.|Unknown|2025Cited by 0
Distinct IL-1β and TNF driven inflammatory responses in Non-typable Haemophilus influenzae infection in bronchiectasisJames D. Chalmers, Jennifer S. Pollock, Francesco Blasi et al.|Unknown|2025Cited by 0